VRCA News and Press, Verrica Pharmaceuticals Inc. From 08/23/23

Verrica’s product YCANTH™ is the first and only FDA-approved treatment for molluscum, a highly contagious viral skin infection affecting approximately 6 million people annually in the United States, primarily children YCANTH™ is expected to be available for commerci...

Presentation highlights the antitumor response of VP-315 for the non-surgical treatment of Basal Cell Carcinoma (BCC) as determined by clinical and histological lesion clearance There are approximately 3-4 million diagnoses of basal cell carcinomas in the U.S. each year, with a high unm...

2023-08-08 08:01:09 ET Verrica Pharmaceuticals press release ( NASDAQ: VRCA ): Q2 GAAP EPS of -$0.24 misses by $0.02 . Revenue of $0.18M (-10.0% Y/Y) beats by $0.11M . As of June 30, 2023, Verrica had aggregate cash and cash equivalents of $55.1 million. ...

– In July, FDA approved YCANTH™ for the treatment of molluscum, a highly contagious viral skin infection affecting approximately 6 million people annually in the United States, primarily children – – YCANTH™ launch expected by September 2023 –...

WEST CHESTER, Pa., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the acceptance of...

– Verrica received $50M upon the close of the transaction; $75M of additional capital available in tranches based on the achievement of certain revenue milestones – – Proceeds from the transaction to support the commercialization of YCANTH™, which was approved ...

2023-07-25 08:19:12 ET Electra Battery Materials  ( NASDAQ: ELBM ) +66% . Bullfrog AI Holdings ( BFRG ) +33% a nnounces Issuance of U.S. Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer. Enzo Biochem ( ENZ ) +18% ...

2023-07-24 15:16:36 ET Shares of Verrica Pharmaceuticals (NASDAQ: VRCA) were down more than 30% as of 2:45 p.m. on Monday. The company, which specializes in dermatology therapeutics, said it was entering into an agreement for as much as $125 million in financing to fund operations. ...

2023-07-24 10:09:58 ET Gainers: Armata Pharmaceuticals ( ARMP ) +19% . Janux Therapeutics ( JANX ) +11% . Amylyx Pharmaceuticals ( AMLX ) +8% . Coherus BioSciences ( CHRS ) +7% . Nuwellis ( NUWE ) +7% . Losers: Kodiak...

2023-07-24 08:34:47 ET Kodiak Sciences ( KOD ) -53% announces topline results from its phase 3 Studies of tarcocimab tedromer in Neovascular age-related macular degeneration and diabetic macular edema. Contango Ore ( CTGO ) -25% . 22nd Century Group ( XXII ...